The medical technology company’s new business unit includes AI-enabled products, BD said in a Sept. 3 news release. The acquisition of California-based Edwards Lifesciences cost $4.2 billion.
Katie Szyman, who has served as corporate vice president of the business under Edwards since 2015, is now worldwide president of BD Advanced Patient Monitoring.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
